Trending stocks and marketinsights, made visual.
Data-driven insights into stocks and investing themes. Our visual newsletter takes 5 minutes to read and it’s completely free.
Stories
Data Centers Are Becoming Power Hungry
IPO Money is Back
Texas Tapped The Brakes on Data Centers
Business AI Adoption is Still Uneven
The AI Boom Hit The Factory Floor
Amazon's AI Buildout Has a Cash Cost
Korea's Export Boom is an AI Chip Story
Options Trading Keeps Setting Records
Stock Ideas
View all ideasProtagonist Therapeutics, Inc
Protagonist Therapeutics is a biotech therapeutics leader trading in an established uptrend with strong relative strength, intermittent GAAP profitability, and a recovering revenue run-rate that merits watching.
Biotech TherapeuticsDropbox, Inc.
Dropbox is positioned for renewed enterprise software momentum after sequential revenue acceleration and a validated Stage 1 to 2 base breakout backed by strong demand volume.
Enterprise & Vertical SoftwareTg Therapeutics, Inc.
Tg Therapeutics has shifted to commercial growth, with quarterly revenue rising from $63.5M in 2024Q1 to $240.3M in 2026Q2 and substantial institutional sponsorship.
Biotech TherapeuticsArrowhead Pharmaceuticals, Inc.
Arrowhead has moved into material reported revenue and improving GAAP diluted EPS while trading in an established uptrend with heavy institutional ownership and strong relative strength.
Biotech TherapeuticsExelixis, Inc.
Exelixis pairs steady mid-teens revenue growth and rising GAAP diluted EPS with a confirmed Stage‑2 technical uptrend and strong relative strength within oncology therapeutics.
Biotech TherapeuticsKrystal Biotech, Inc.
Krystal Biotech is a commercial-stage gene therapy company that grew quarterly revenue from $8.6M to $119.2M while delivering consecutive GAAP profits, positioning it as a timely leader in dermatology biotech.
Biotech TherapeuticsMarket insights
View all insightsVendor consolidation is shifting demand from legacy platforms
Braze’s win commentary signals that enterprises are consolidating customer-engagement software and replacing legacy marketing clouds and point solutions. This supports competitive share gains for integrated platforms while pressuring incumbent vendors exposed to displacement.
Read insight →Enterprise AI adoption is reshaping customer engagement
AI adoption is moving beyond experimentation into customer messaging and product-personalization workflows. The read-through is positive for software vendors that can attach AI to measurable engagement use cases, though the quote directly quantifies adoption only at Braze.
Read insight →Cloud marketplaces are becoming enterprise software channels
Enterprise software distribution is increasingly influenced by existing cloud commitments and marketplace procurement. This favors vendors that integrate with hyperscaler sales channels and can use those channels to reach new geographies and verticals.
Read insight →Market insights, made visual.
Get data-driven insights into stocks and investing themes in a free newsletter that takes 5 minutes to read.